Immix Biopharma, Inc. (IMMX)
4.70
-0.01
(-0.21%)
USD |
NASDAQ |
Jan 16, 16:00
4.70
0.00 (0.00%)
After-Hours: 05:51
Immix Biopharma Total Assets (Quarterly): 20.08M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| CEL-SCI Corp. | 28.16M |
| AIM ImmunoTech, Inc. | 5.494M |
| IGC Pharma, Inc. | 9.743M |
| NovaBay Pharmaceuticals, Inc. | 3.487M |
| Protalix Biotherapeutics, Inc. | 82.26M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 11.82M |
| Shareholders Equity (Quarterly) | 8.265M |
| Debt to Equity Ratio | 0.1339 |
| Current Ratio | 1.528 |
| Net Debt Paydown Yield | -0.00% |